Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05179785 · ClinicalTrials.gov registry record · NA
Examining the Effect of EEG-guided Theta Burst Stimulation in Bipolar Disorder
A NA study, sponsored by Mary Phillips, MD MD (Cantab).
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT05179785 is a NA study that has completed, run by Mary Phillips, MD MD (Cantab). The registered enrollment target is 13 participants.
The verdict
NCT05179785, a NA study, has completed, sponsored by Mary Phillips, MD MD (Cantab).
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
Bipolar Disorder (BD) is a common and highly debilitating psychiatric disorder, however, the predisposing brain mechanisms are poorly understood. Here, the investigators will conduct a proof of concept study that will examine the effect of electroencephalography (EEG)-guided theta burst stimulation (TBS) on reducing mania/hypomania-related affect and reward driven behavior in adults with BD. The investigators hypothesize that TBS will reduce mania/hypomania-related affect and reward driven behavior in adults with BD.
Interventions
- DEVICE Intermittent Theta Burst Stimulation (iTBS)
- DEVICE Continuous Theta Burst Stimulation (cTBS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2022-03-23 |
| Est. Completion | 2023-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05179785
The ClinicalTrials.gov registry entry for NCT05179785 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mary Phillips, MD MD (Cantab), which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intermittent Theta Burst Stimulation (iTBS) is the first listed.
NCT05179785 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05179785 about?
NCT05179785 is a clinical study titled "Examining the Effect of EEG-guided Theta Burst Stimulation in Bipolar Disorder". Bipolar Disorder (BD) is a common and highly debilitating psychiatric disorder, however, the predisposing brain mechanisms are poorly understood. Here, the investigators will conduct a proof of concept study that will examine the effect of electroencephalography (EEG)-guided theta burst stimulation ...
What is the current status of trial NCT05179785?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2022-03-23. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT05179785?
The interventions under investigation include: Intermittent Theta Burst Stimulation (iTBS) (DEVICE), Continuous Theta Burst Stimulation (cTBS) (DEVICE).
Who is sponsoring clinical trial NCT05179785?
This trial is sponsored by Mary Phillips, MD MD (Cantab), which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.